返回
C
Charité – UniversitäTsmedizin Berlin
学者数561
论文数200
被引数2
关联论文 (200)
发表时间
Reply to Letter: “Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring” by Saccà and Pelto Regarding “Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab”回复函:“补体活性测定作为拉尼珠单抗治疗监测生物标志物的局限性”由Saccà和Pelto就“拉尼珠单抗和依库珠单抗对经典和替代补体通路的抑制作用”一文提出

